HKD 0.78
(-1.27%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 2.06 Billion HKD | 15.3% |
2022 | 1.79 Billion HKD | 24.88% |
2021 | 1.43 Billion HKD | 6.11% |
2020 | 1.35 Billion HKD | -33.77% |
2019 | 2.04 Billion HKD | -0.47% |
2018 | 2.05 Billion HKD | 10.15% |
2017 | 1.86 Billion HKD | 9.75% |
2016 | 1.69 Billion HKD | -0.75% |
2015 | 1.71 Billion HKD | 5.22% |
2014 | 1.62 Billion HKD | -3.44% |
2013 | 1.68 Billion HKD | -0.1% |
2012 | 1.68 Billion HKD | 14.26% |
2011 | 1.47 Billion HKD | 35.86% |
2010 | 1.08 Billion HKD | 33.85% |
2009 | 811.33 Million HKD | -7.39% |
2008 | 876.04 Million HKD | 3.55% |
2007 | 846.01 Million HKD | 23.07% |
2006 | 687.4 Million HKD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 511.67 Million HKD | 0.0% |
2024 Q1 | 511.67 Million HKD | -55.29% |
2023 Q3 | 572.24 Million HKD | -37.99% |
2023 Q4 | 1.14 Billion HKD | 100.0% |
2023 Q1 | 461.39 Million HKD | -48.87% |
2023 FY | 2.06 Billion HKD | 15.3% |
2023 Q2 | 922.79 Million HKD | 100.0% |
2022 Q2 | 890.55 Million HKD | 100.0% |
2022 Q1 | 445.27 Million HKD | -46.88% |
2022 Q4 | 902.47 Million HKD | 100.0% |
2022 Q3 | 451.23 Million HKD | -49.33% |
2022 FY | 1.79 Billion HKD | 24.88% |
2021 Q2 | 597.58 Million HKD | 100.0% |
2021 Q4 | 838.24 Million HKD | 100.0% |
2021 Q1 | 298.79 Million HKD | -54.8% |
2021 FY | 1.43 Billion HKD | 6.11% |
2021 Q3 | 419.12 Million HKD | -29.86% |
2020 FY | 1.35 Billion HKD | -33.77% |
2020 Q2 | 692.07 Million HKD | 100.0% |
2020 Q4 | 661.02 Million HKD | 100.0% |
2020 Q1 | 346.03 Million HKD | -68.29% |
2020 Q3 | 330.51 Million HKD | -52.24% |
2019 Q4 | 1.09 Billion HKD | 100.0% |
2019 FY | 2.04 Billion HKD | -0.47% |
2019 Q3 | 545.62 Million HKD | -42.68% |
2019 Q2 | 951.85 Million HKD | 100.0% |
2019 Q1 | 475.92 Million HKD | -14.92% |
2018 FY | 2.05 Billion HKD | 10.15% |
2018 Q1 | 466.96 Million HKD | -8.37% |
2018 Q2 | 466.96 Million HKD | 0.0% |
2018 Q3 | 559.38 Million HKD | 19.79% |
2018 Q4 | 559.38 Million HKD | 0.0% |
2017 Q2 | 422.13 Million HKD | 0.0% |
2017 FY | 1.86 Billion HKD | 9.75% |
2017 Q1 | 422.13 Million HKD | -8.85% |
2017 Q4 | 509.64 Million HKD | 0.0% |
2017 Q3 | 509.64 Million HKD | 20.73% |
2016 FY | 1.69 Billion HKD | -0.75% |
2016 Q1 | 385.89 Million HKD | -11.22% |
2016 Q3 | 463.1 Million HKD | 20.01% |
2016 Q2 | 385.89 Million HKD | 0.0% |
2016 Q4 | 463.1 Million HKD | 0.0% |
2015 Q3 | 434.68 Million HKD | 3.31% |
2015 Q2 | 420.76 Million HKD | 0.0% |
2015 Q1 | 420.76 Million HKD | -1.99% |
2015 Q4 | 434.68 Million HKD | 0.0% |
2015 FY | 1.71 Billion HKD | 5.22% |
2014 Q1 | 383.69 Million HKD | -11.61% |
2014 Q2 | 383.69 Million HKD | 0.0% |
2014 Q4 | 429.31 Million HKD | 0.0% |
2014 Q3 | 429.31 Million HKD | 11.89% |
2014 FY | 1.62 Billion HKD | -3.44% |
2013 Q3 | 434.1 Million HKD | 6.43% |
2013 FY | 1.68 Billion HKD | -0.1% |
2013 Q4 | 434.1 Million HKD | 0.0% |
2013 Q2 | 407.89 Million HKD | 0.0% |
2013 Q1 | 407.89 Million HKD | -11.01% |
2012 Q1 | 421.43 Million HKD | 0.0% |
2012 FY | 1.68 Billion HKD | 14.26% |
2012 Q4 | 458.37 Million HKD | 0.0% |
2012 Q3 | 458.37 Million HKD | 8.77% |
2012 Q2 | 421.43 Million HKD | 0.0% |
2011 FY | 1.47 Billion HKD | 35.86% |
2011 Q4 | 421.43 Million HKD | 14.26% |
2011 Q3 | 368.84 Million HKD | 0.0% |
2011 Q2 | 368.84 Million HKD | 0.0% |
2011 Q1 | 368.84 Million HKD | 0.0% |
2010 Q2 | 271.48 Million HKD | 0.0% |
2010 Q1 | 271.48 Million HKD | 0.0% |
2010 FY | 1.08 Billion HKD | 33.85% |
2010 Q4 | 368.84 Million HKD | 35.86% |
2010 Q3 | 271.48 Million HKD | 0.0% |
2009 Q4 | 271.48 Million HKD | 33.85% |
2009 FY | 811.33 Million HKD | -7.39% |
2009 Q1 | 202.83 Million HKD | 0.0% |
2009 Q2 | 202.83 Million HKD | 0.0% |
2009 Q3 | 202.83 Million HKD | 0.0% |
2008 Q1 | 219.01 Million HKD | 0.0% |
2008 FY | 876.04 Million HKD | 3.55% |
2008 Q3 | 219.01 Million HKD | 0.0% |
2008 Q2 | 219.01 Million HKD | 0.0% |
2008 Q4 | 202.83 Million HKD | -7.39% |
2007 Q3 | 211.5 Million HKD | 0.0% |
2007 Q4 | 219.01 Million HKD | 3.55% |
2007 FY | 846.01 Million HKD | 23.07% |
2007 Q1 | 211.5 Million HKD | 0.0% |
2007 Q2 | 211.5 Million HKD | 0.0% |
2006 FY | 687.4 Million HKD | 0.0% |
2006 Q4 | 211.5 Million HKD | 23.07% |
2006 Q1 | 171.85 Million HKD | 0.0% |
2006 Q2 | 171.85 Million HKD | 0.0% |
2006 Q3 | 171.85 Million HKD | 0.0% |
2005 Q4 | 171.85 Million HKD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 336.01 Million HKD | -515.232% |
Innovative Pharmaceutical Biotech Limited | 6.59 Million HKD | -31255.574% |
China Overseas Nuoxin International Holdings Limited | 180.99 Million HKD | -1042.171% |
Prosperous Future Holdings Limited | 470.33 Million HKD | -339.535% |
Huasheng International Holding Limited | 565.9 Million HKD | -265.303% |
Fourace Industries Group Holdings Limited | 268.02 Million HKD | -671.301% |
Evergreen Products Group Limited | 979.24 Million HKD | -111.11% |
EC Healthcare | 4.21 Billion HKD | 50.908% |
Blue Moon Group Holdings Limited | 7.32 Billion HKD | 71.772% |
SuperRobotics Holdings Limited | 15.08 Million HKD | -13607.798% |
Takbo Group Holdings Limited | 215.59 Million HKD | -858.887% |
Hyfusin Group Holdings Limited | 866.25 Million HKD | -138.646% |